- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urothelial Carcinoma Ureteral Location
Total 699 results
-
Sheba Medical CenterRecruiting
-
CHU de Quebec-Universite LavalCancer Research SocietyWithdrawnMetastatic Urothelial CarcinomaCanada
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMetastatic Urothelial CarcinomaItaly
-
Lee's Pharmaceutical LimitedActive, not recruitingAdvanced Urothelial CarcinomaChina
-
National Taiwan University HospitalUnknownThe Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial CarcinomaBladder Urothelial CarcinomaTaiwan
-
Novartis PharmaceuticalsCompletedUrothelial CancerUnited States, Spain, Taiwan, Germany, Canada, United Kingdom, Italy, Austria
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdNot yet recruitingMuscle-invasive Urothelial CarcinomaJapan
-
Sohag UniversityRecruitingUrinary Bladder Urothelial CarcinomaEgypt
-
Jinling Hospital, ChinaRecruitingCarcinoma | Upper Tract Urothelial Carcinoma | UTUCChina
-
AnchorDx Medical Co., Ltd.Peking University First Hospital; Peking Union Medical College Hospital; Peking... and other collaboratorsRecruitingUpper Tract Urothelial CarcinomaChina
-
Association Pour La Recherche des Thérapeutiques...Active, not recruitingInfiltrating Bladder Urothelial CarcinomaFrance
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingUpper Tract Urothelial CarcinomaUnited States
-
RenJi HospitalUnknown
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
Associació per a la Recerca Oncologica, SpainTakeda; Pivotal S.L.Unknown
-
National Cancer Institute (NCI)TerminatedUrothelial CancerUnited States
-
Tata Memorial CentreNot yet recruitingNon-Invasive Bladder Urothelial Carcinoma
-
YULISUOno Pharmaceutical Co. LtdRecruitingUpper Urinary Tract Urothelial CarcinomaTaiwan
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Urothelial CarcinomaChina
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
UNICANCERCompletedKRAS Gene Mutation | Infiltrating Urothelial CarcinomaFrance
-
National Cancer Institute (NCI)RecruitingMetastatic Urothelial Carcinoma | Stage IV Bladder Cancer AJCC v8 | Platinum-Resistant Urothelial CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Urothelial Carcinoma | Stage IV Bladder Urothelial CarcinomaUnited States
-
Associació per a la Recerca Oncologica, SpainPivotal S.L.; Merck, S.L., SpainCompletedMetastatic Urothelial CancerSpain
-
Astellas Pharma IncSeagen Inc.CompletedMetastatic Urothelial CancerJapan
-
Incyte CorporationCompletedUC (Urothelial Cancer)United States, Netherlands, Spain, Denmark, Belgium, Israel, Italy, Germany, France, Japan, United Kingdom
-
Spanish Oncology Genito-Urinary GroupRoche Pharma AGCompletedLocally Advanced or Metastatic Urothelial CarcinomaSpain
-
Xiangya Hospital of Central South UniversityHunan Cancer Hospital; The Third Xiangya Hospital of Central South University; Hunan Provincial People's Hospital and other collaboratorsCompletedHigh-Grade Upper Tract Urothelial CarcinomaChina
-
University of FlorenceCareggi Hospital; University of Milano Bicocca; Fondazione C.N.R./Regione Toscana...RecruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma | Urothelial Neoplasm | Urothelial Carcinoma in SituItaly
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingMetastatic Urothelial CarcinomaChina
-
National Cancer Institute (NCI)WithdrawnUrothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8Canada
-
Taiho Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingAdvanced and Metastatic Urothelial CancerSpain, United States, France
-
Shandong New Time Pharmaceutical Co., LTDUnknownLocally Advanced or Metastatic Urothelial Cell Carcinoma
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Squamous Cell Carcinoma of the BladderUnited States
-
RenJi HospitalXiangya Hospital of Central South University; Shanghai Zhongshan Hospital; West... and other collaboratorsRecruitingUpper Tract Urothelial Carcinoma Receiving Kidney-sparing TherapyChina
-
Centre Hospitalier Universitaire de NīmesINSERM U1194, Institut de Recherche en Cancérologie de Montpellier, Campus...RecruitingTumor | Xenograft Model | Upper Urinary Tract Urothelial Carcinoma | NephroureterectomyFrance
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, France, Belgium, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Australia, Netherlands, Japan, Germany, Ukraine, Canada, Ireland, Italy, Poland, Russian Federation
-
Merck Sharp & Dohme LLCCompletedUrothelial Carcinoma Associated 1 RNA, Human
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Bladder Carcinoma | Metastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Bladder Urothelial Carcinoma | Metastatic Transitional Cell CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedMetastatic Urothelial CarcinomaUnited States
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, Spain, Hungary, Israel, United Kingdom, Korea, Republic of, Taiwan, Denmark, France, Netherlands, Italy, Canada, Japan, Turkey, Germany, Ireland, Australia, Russian Federation
-
Brigham and Women's HospitalNot yet recruitingMuscle Invasive Bladder Urothelial CarcinomaUnited States
-
University of MichiganCompletedUrinary Tract Urothelial CarcinomaUnited States
-
TJ Biopharma Co., Ltd.WithdrawnFirst-line Non-small-cell Lung Cancer | First-line Urothelial Carcinoma | Second-line Urothelial Carcinoma | Second-line MelanomaChina
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseRecruitingUrothelial Carcinoma | Non-Invasive Bladder Urothelial CarcinomaUnited States
-
University of UtahExelixisActive, not recruitingBladder Cancer | Metastatic Urothelial CarcinomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
Flare Therapeutics Inc.RecruitingAdvanced Solid Tumors Cancer | Advanced Urothelial Carcinoma | Open Label | Oral Drug AdministrationUnited States